
News|Articles|November 14, 2013
PODCAST: Hepatitis C overview
Hepatitis C discussion with Eliav Barr, MD, vice president, infectious disease project and pipeline lead at Merck Research Laboratories in West Point, Pa.
Advertisement
Listen to Eliav Barr, MD, vice president, infectious disease project and pipeline lead at Merck Research Laboratories in West Point, Pa., discuss with Formulary the cost burden of hepatitis C to the healthcare system, what to expect in the hepatitis pipeline in the near future, and the most effective way to manage these drugs on the formulary.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
3 things to know about CVS Health’s 2025 earnings
3
IRA price reductions to have little impact on future innovation, analysis finds
4
A conversation about the consequences of Florida’s HIV medication cuts with Colleen Kelley, M.D., M.P.H., immediate past chair of the HIVMA and HIV specialist in Atlanta, Georgia
5

























